|
|
|
Insider
Information: |
Ross Leonard S |
Relationship: |
|
City: |
Watertown |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
90,044 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$39,844 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
90,044 |
|
|
Total
Value |
$39,844 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
EyePoint Pharmaceuticals Inc |
EYPT |
|
2019-06-27 |
90,044 |
2015-08-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2019-06-27 |
4 |
D |
$1.65 |
$3,236 |
D/D |
(1,961) |
90,044 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2019-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
92,005 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2019-06-14 |
4 |
D |
$1.53 |
$3,663 |
D/D |
(2,394) |
85,338 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2019-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,280 |
87,732 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2019-04-01 |
4 |
OE |
$1.81 |
$9,050 |
D/D |
5,000 |
79,452 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2019-03-19 |
4 |
D |
$2.47 |
$4,285 |
D/D |
(1,735) |
74,452 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2018-12-22 |
4 |
D |
$1.65 |
$30,561 |
D/D |
(18,522) |
76,187 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2018-12-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,892 |
94,709 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2018-10-12 |
4 |
D |
$3.23 |
$9,512 |
D/D |
(2,945) |
31,817 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2018-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
34,762 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2018-06-27 |
4 |
D |
$1.86 |
$3,541 |
D/D |
(1,904) |
14,762 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2018-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,666 |
16,666 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
See Remarks |
|
2018-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
Vice President, Finance |
|
2016-01-04 |
4 |
AS |
$4.70 |
$23,500 |
D/D |
(5,000) |
0 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
Vice President, Finance |
|
2016-01-04 |
4 |
OE |
$1.81 |
$9,050 |
D/D |
5,000 |
5,000 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
Vice President, Finance |
|
2015-12-22 |
4 |
OE |
$1.81 |
$61,450 |
D/D |
33,950 |
33,950 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
Vice President, Finance |
|
2015-12-22 |
4 |
AS |
$5.39 |
$182,991 |
D/D |
(33,950) |
0 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
Vice President, Finance |
|
2015-12-01 |
4 |
AS |
$4.06 |
$4,263 |
D/D |
(1,050) |
0 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
Vice President, Finance |
|
2015-12-01 |
4 |
OE |
$1.81 |
$1,901 |
D/D |
1,050 |
1,050 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
Vice President, Finance |
|
2015-08-03 |
4 |
AS |
$4.05 |
$20,250 |
D/D |
(5,000) |
0 |
0 |
- |
|
EYPT |
EyePoint Pharmaceuticals ... |
Vice President, Finance |
|
2015-08-03 |
4 |
OE |
$1.81 |
$9,050 |
D/D |
5,000 |
5,000 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|